EGFR and squamous cell carcinoma: Twelve patients were diagnosed as having adenocarcinoma including two cases with sensitive EGFR mutations (Patients 5 and 12), and there was one patient with squamous cell carcinoma, one patient with pleomorphic carcinoma; the remaining patient was diagnosed as having non-histologically-specified non-small cell lung cancer.